Sentynl Therapeutics, Inc. clinical trials
Acquired by Zydus Lifesciences Limited, Jan 19, 2017 · source ↗
The registry lists 2 studies whose lead sponsor is Sentynl Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 2, 2026.
Before and after it joined Zydus Lifesciences Limited
- First submitted before Sentynl Therapeutics, Inc. became part of Zydus Lifesciences Limited
- 0
- First submitted after Sentynl Therapeutics, Inc. became part of Zydus Lifesciences Limited
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Sentynl Therapeutics, Inc.2 studies
Something wrong with this grouping? Tell us on the Zydus Lifesciences Limited page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Zydus Lifesciences Limited studies →
- Copper Histidinate Treatment for Menkes DiseaseApproved for marketingNCT04074512
Sponsor listed in the registry: Sentynl Therapeutics, Inc. · First submitted after Sentynl Therapeutics, Inc. became part of Zydus Lifesciences Limited
- Long Term Follow-up on Menkes Disease PatientsActive, not recruitingNCT04337684
Sponsor listed in the registry: Sentynl Therapeutics, Inc. · First submitted after Sentynl Therapeutics, Inc. became part of Zydus Lifesciences Limited